You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
西藏藥業(600211.SH)擬購買臨港奉賢園區房屋進行疫苗生產線建設
格隆匯 09-07 18:17

格隆匯9月7日丨西藏藥業(600211.SH)公佈,公司於2020年6月16日披露了關於與斯微生物獨家戰略合作事項:公司與斯微生物合作研發,獲得相關疫苗的全球獨家開發、生產、使用及商業化權利,公司不成為相關疫苗的權益所有人;同時雙方約定儘快建立能夠滿足目標產品商業化供應的生產廠。截止本公告日,相關疫苗尚未取得臨牀批件。

為了將來疫苗生產需要,公司經過考察和調研後,擬向上海臨港華平經濟發展有限公司(以下簡稱“華平發展”)購買位於中國上海市臨港奉賢園區臨港智造園六期項目的房地產進行生產線建設。第一期擬購買房屋建築面積約2.74萬平方米,單價約10500元/每平方米(最終成交價格以第三方評估價為準),合計約2.88億元人民幣,相關房屋買賣合同尚未簽署;第二期擬購買土地約70畝,具體將視項目推進情況另行協商。上述房屋和土地預計總金額約3.4億元人民幣。項目涉及的土地性質為國有土地,土地用途為工業用地,土地使用權年限至2067年11月23日屆滿。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account